Cargando…

Exploring the effect of vitamin D(3) supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis

BACKGROUND: Epstein–Barr virus (EBV) infection and vitamin D insufficiency are potentially interacting risk factors for multiple sclerosis (MS). OBJECTIVES: To investigate the effect of high-dose vitamin D(3) supplements on antibody levels against the EBV nuclear antigen-1 (EBNA-1) in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rolf, Linda, Muris, Anne-Hilde, Mathias, Amandine, Du Pasquier, Renaud, Koneczny, Inga, Disanto, Giulio, Kuhle, Jens, Ramagopalan, Sreeram, Damoiseaux, Jan, Smolders, Joost, Hupperts, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108041/ https://www.ncbi.nlm.nih.gov/pubmed/28731372 http://dx.doi.org/10.1177/1352458517722646

Ejemplares similares

Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
por: Mimpen, Max, et al.
Publicado: (2020)

Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up
por: Muris, Anne-Hilde, et al.
Publicado: (2016)

Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions
por: Muris, Anne-Hilde, et al.
Publicado: (2014)

Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis
por: Chalkou, Konstantina, et al.
Publicado: (2021)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
por: Zecca, Chiara, et al.
Publicado: (2020)

Stress-Axis Regulation by Vitamin D(3) in Multiple Sclerosis
por: Rolf, Linda, et al.
Publicado: (2018)

Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis
por: Mimpen, Max, et al.
Publicado: (2021)

Real‐world evaluation of ocrelizumab in multiple sclerosis: A systematic review
por: Montalban, Xavier, et al.
Publicado: (2023)

Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs
por: Watson, Corey T., et al.
Publicado: (2012)

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2009)

Safety and T Cell Modulating Effects of High Dose Vitamin D(3) Supplementation in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2010)

Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies
por: Ramagopalan, Sreeram V, et al.
Publicado: (2013)

Season of birth and anorexia nervosa
por: Disanto, Giulio, et al.
Publicado: (2011)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Age-Associated Hyper-Methylated Regions in the Human Brain Overlap with Bivalent Chromatin Domains
por: Watson, Corey T., et al.
Publicado: (2012)

Protein-Protein Interaction Analysis Highlights Additional Loci of Interest for Multiple Sclerosis
por: Ragnedda, Giammario, et al.
Publicado: (2012)

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
por: Caporro, Matteo, et al.
Publicado: (2014)

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
por: Lorscheider, Johannes, et al.
Publicado: (2020)

Smoking and Multiple Sclerosis: An Updated Meta-Analysis
por: Handel, Adam E., et al.
Publicado: (2011)

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
por: Handel, Adam E., et al.
Publicado: (2010)

National survey of UK medical students on the perception of neurology
por: Pakpoor, Julia, et al.
Publicado: (2014)

Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression
por: Handel, Adam E, et al.
Publicado: (2013)

Neurofilament light chain predicts disease activity in relapsing-remitting MS
por: Varhaug, Kristin N., et al.
Publicado: (2017)

Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease
por: Gallone, Giuseppe, et al.
Publicado: (2017)

Month of birth, vitamin D and risk of immune-mediated disease: a case control study
por: Disanto, Giulio, et al.
Publicado: (2012)

The Engagement Between Vitamin D and the Immune System: Is Consolidation by a Marriage to Be Expected?
por: Damoiseaux, Jan, et al.
Publicado: (2018)

Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells
por: Disanto, Giulio, et al.
Publicado: (2012)

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015)

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
por: Kappos, Ludwig, et al.
Publicado: (2015)

The Association of EBV and HHV-6 Viral Load with Different NK and CD8(+) T Cell Subsets in The Acute Phase of Relapsing-Remitting Multiple Sclerosis
por: Salehi, Zahra, et al.
Publicado: (2021)

Relapsing/remitting type 1 diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2017)

Seasonal Distribution of Psychiatric Births in England
por: Disanto, Giulio, et al.
Publicado: (2012)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

A Case of Relapsing-Remitting Tumefactive Demyelination
por: Wadhwa, Ankur, et al.
Publicado: (2019)

Relapsing and remitting viral diseases of the nervous system
por: Johnson, Richard T.
Publicado: (1984)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis
por: Meira, Maria, et al.
Publicado: (2014)

Effect of Vitamin D Supplements on Relapse Rate and Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
por: Hanaei, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0rvpo1ffnjbgmnog6s97ulkq5i